1 Report Overview

　1.1 Study Scope

　1.2 Key Market Segments

　1.3 Players Covered: Ranking by Precision Cancer Diagnostic Tests Revenue

　1.4 Market Analysis by Type

　　1.4.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type: 2020 VS 2026

　　1.4.2 Imaging

　　1.4.3 Molecular

　　1.4.4 Histology/Cytology

　　1.4.5 Tumor Marker Immunoassays

　　1.4.6 POC Colon Cancer Tests

　1.5 Market by Application

　　1.5.1 Global Precision Cancer Diagnostic Tests Market Share by Application: 2020 VS 2026

　　1.5.2 Hospital

　　1.5.3 Clinic

　　1.5.4 Other

　1.6 Study Objectives

　1.7 Years Considered

2 Global Growth Trends by Regions

　2.1 Precision Cancer Diagnostic Tests Market Perspective (2015-2026)

　2.2 Precision Cancer Diagnostic Tests Growth Trends by Regions

　　2.2.1 Precision Cancer Diagnostic Tests Market Size by Regions: 2015 VS 2020 VS 2026

　　2.2.2 Precision Cancer Diagnostic Tests Historic Market Share by Regions (2015-2020)

　　2.2.3 Precision Cancer Diagnostic Tests Forecasted Market Size by Regions (2021-2026)

　2.3 Industry Trends and Growth Strategy

　　2.3.1 Market Top Trends

　　2.3.2 Market Drivers

　　2.3.3 Market Challenges

　　2.3.4 Porter's Five Forces Analysis

　　2.3.5 Precision Cancer Diagnostic Tests Market Growth Strategy

　　2.3.6 Primary Interviews with Key Precision Cancer Diagnostic Tests Players (Opinion Leaders)

3 Competition Landscape by Key Players

　3.1 Global Top Precision Cancer Diagnostic Tests Players by Market Size

　　3.1.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue (2015-2020)

　　3.1.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Players (2015-2020)

　　3.1.3 Global Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

　3.2 Global Precision Cancer Diagnostic Tests Market Concentration Ratio

　　3.2.1 Global Precision Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)

　　3.2.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Tests Revenue in 2019

　3.3 Precision Cancer Diagnostic Tests Key Players Head office and Area Served

　3.4 Key Players Precision Cancer Diagnostic Tests Product Solution and Service

　3.5 Date of Enter into Precision Cancer Diagnostic Tests Market

　3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

　4.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Type (2015-2020)

　4.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2021-2026)

5 Precision Cancer Diagnostic Tests Breakdown Data by Application (2015-2026)

　5.1 Global Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

　5.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2021-2026)

6 North America

　6.1 North America Precision Cancer Diagnostic Tests Market Size (2015-2020)

　6.2 Precision Cancer Diagnostic Tests Key Players in North America (2019-2020)

　6.3 North America Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)

　6.4 North America Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

7 Europe

轉?自：http://www.qdlaimaiche.com/3/68/Global-Precision-Cancer-Diagnostic-Tests-Market-Size-Status-and-Forecast-2020-2026.html

　7.1 Europe Precision Cancer Diagnostic Tests Market Size (2015-2020)

　7.2 Precision Cancer Diagnostic Tests Key Players in Europe (2019-2020)

　7.3 Europe Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)

　7.4 Europe Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

8 China

　8.1 China Precision Cancer Diagnostic Tests Market Size (2015-2020)

　8.2 Precision Cancer Diagnostic Tests Key Players in China (2019-2020)

　8.3 China Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)

　8.4 China Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

9 Japan

　9.1 Japan Precision Cancer Diagnostic Tests Market Size (2015-2020)

　9.2 Precision Cancer Diagnostic Tests Key Players in Japan (2019-2020)

　9.3 Japan Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)

　9.4 Japan Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

10 Southeast Asia

　10.1 Southeast Asia Precision Cancer Diagnostic Tests Market Size (2015-2020)

　10.2 Precision Cancer Diagnostic Tests Key Players in Southeast Asia (2019-2020)

　10.3 Southeast Asia Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)

　10.4 Southeast Asia Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

11 India

　11.1 India Precision Cancer Diagnostic Tests Market Size (2015-2020)

　11.2 Precision Cancer Diagnostic Tests Key Players in India (2019-2020)

　11.3 India Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)

　11.4 India Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

12 Central & South America

　12.1 Central & South America Precision Cancer Diagnostic Tests Market Size (2015-2020)

　12.2 Precision Cancer Diagnostic Tests Key Players in Central & South America (2019-2020)

　12.3 Central & South America Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)

　12.4 Central & South America Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

13 Key Players Profiles

　13.1 Company 1

　　13.1.1 Company 1 Company Details

　　13.1.2 Company 1 Business Overview and Its Total Revenue

　　13.1.3 Company 1 Precision Cancer Diagnostic Tests Introduction

　　13.1.4 Company 1 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020))

　　13.1.5 Company 1 Recent Development

　13.2 Company 2

　　13.2.1 Company 2 Company Details

　　13.2.2 Company 2 Business Overview and Its Total Revenue

　　13.2.3 Company 2 Precision Cancer Diagnostic Tests Introduction

　　13.2.4 Company 2 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　13.2.5 Company 2 Recent Development

　13.3 Company 3

　　13.3.1 Company 3 Company Details

　　13.3.2 Company 3 Business Overview and Its Total Revenue

　　13.3.3 Company 3 Precision Cancer Diagnostic Tests Introduction

　　13.3.4 Company 3 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　13.3.5 Company 3 Recent Development

　13.4 Company 4

　　13.4.1 Company 4 Company Details

　　13.4.2 Company 4 Business Overview and Its Total Revenue

　　13.4.3 Company 4 Precision Cancer Diagnostic Tests Introduction

　　13.4.4 Company 4 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　13.4.5 Company 4 Recent Development

　13.5 Company 5

　　13.5.1 Company 5 Company Details

　　13.5.2 Company 5 Business Overview and Its Total Revenue

　　13.5.3 Company 5 Precision Cancer Diagnostic Tests Introduction

　　13.5.4 Company 5 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　13.5.5 Company 5 Recent Development

　13.6 Company 6

　　13.6.1 Company 6 Company Details

　　13.6.2 Company 6 Business Overview and Its Total Revenue

　　13.6.3 Company 6 Precision Cancer Diagnostic Tests Introduction

　　13.6.4 Company 6 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　13.6.5 Company 6 Recent Development

　13.7 Company 7

　　13.7.1 Company 7 Company Details

　　13.7.2 Company 7 Business Overview and Its Total Revenue

　　13.7.3 Company 7 Precision Cancer Diagnostic Tests Introduction

　　13.7.4 Company 7 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　13.7.5 Company 7 Recent Development

　13.8 Company 8

　　13.8.1 Company 8 Company Details

　　13.8.2 Company 8 Business Overview and Its Total Revenue

　　13.8.3 Company 8 Precision Cancer Diagnostic Tests Introduction

　　13.8.4 Company 8 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　13.8.5 Company 8 Recent Development

　13.9 Company 9

　　13.9.1 Company 9 Company Details

　　13.9.2 Company 9 Business Overview and Its Total Revenue

　　13.9.3 Company 9 Precision Cancer Diagnostic Tests Introduction

　　13.9.4 Company 9 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　13.9.5 Company 9 Recent Development

　13.10 Company 10

　　13.10.1 Company 10 Company Details

　　13.10.2 Company 10 Business Overview and Its Total Revenue

　　13.10.3 Company 10 Precision Cancer Diagnostic Tests Introduction

　　13.10.4 Company 10 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　13.10.5 Company 10 Recent Development

　13.11 Company 11

　　10.11.1 Company 11 Company Details

　　10.11.2 Company 11 Business Overview and Its Total Revenue

　　10.11.3 Company 11 Precision Cancer Diagnostic Tests Introduction

　　10.11.4 Company 11 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.11.5 Company 11 Recent Development

　13.12 Company 12

　　10.12.1 Company 12 Company Details

　　10.12.2 Company 12 Business Overview and Its Total Revenue

　　10.12.3 Company 12 Precision Cancer Diagnostic Tests Introduction

　　10.12.4 Company 12 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.12.5 Company 12 Recent Development

　13.13 Company 13

　　10.13.1 Company 13 Company Details

　　10.13.2 Company 13 Business Overview and Its Total Revenue

　　10.13.3 Company 13 Precision Cancer Diagnostic Tests Introduction

　　10.13.4 Company 13 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.13.5 Company 13 Recent Development

　13.14 Company 14

　　10.14.1 Company 14 Company Details

全球精密癌癥診斷測試市場規模，現狀和展望二零二零年至2026年

　　10.14.2 Company 14 Business Overview and Its Total Revenue

　　10.14.3 Company 14 Precision Cancer Diagnostic Tests Introduction

　　10.14.4 Company 14 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.14.5 Company 14 Recent Development

　13.15 Company 15

　　10.15.1 Company 15 Company Details

　　10.15.2 Company 15 Business Overview and Its Total Revenue

　　10.15.3 Company 15 Precision Cancer Diagnostic Tests Introduction

　　10.15.4 Company 15 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.15.5 Company 15 Recent Development

　13.16 Company 16

　　10.16.1 Company 16 Company Details

　　10.16.2 Company 16 Business Overview and Its Total Revenue

　　10.16.3 Company 16 Precision Cancer Diagnostic Tests Introduction

　　10.16.4 Company 16 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.16.5 Company 16 Recent Development

　13.17 Company 17

　　10.17.1 Company 17 Company Details

　　10.17.2 Company 17 Business Overview and Its Total Revenue

　　10.17.3 Company 17 Precision Cancer Diagnostic Tests Introduction

　　10.17.4 Company 17 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.17.5 Company 17 Recent Development

　13.18 Company 18

　　10.18.1 Company 18 Company Details

　　10.18.2 Company 18 Business Overview and Its Total Revenue

　　10.18.3 Company 18 Precision Cancer Diagnostic Tests Introduction

　　10.18.4 Company 18 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.18.5 Company 18 Recent Development

　13.19 Company 19

　　10.19.1 Company 19 Company Details

　　10.19.2 Company 19 Business Overview and Its Total Revenue

　　10.19.3 Company 19 Precision Cancer Diagnostic Tests Introduction

　　10.19.4 Company 19 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.19.5 Company 19 Recent Development

　13.20 Company 20

　　10.20.1 Company 20 Company Details

　　10.20.2 Company 20 Business Overview and Its Total Revenue

　　10.20.3 Company 20 Precision Cancer Diagnostic Tests Introduction

　　10.20.4 Company 20 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.20.5 Company 20 Recent Development

　13.21 Company 21

　　10.21.1 Company 21 Company Details

　　10.21.2 Company 21 Business Overview and Its Total Revenue

　　10.21.3 Company 21 Precision Cancer Diagnostic Tests Introduction

　　10.21.4 Company 21 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.21.5 Company 21 Recent Development

　13.22 Company 22

　　10.22.1 Company 22 Company Details

　　10.22.2 Company 22 Business Overview and Its Total Revenue

　　10.22.3 Company 22 Precision Cancer Diagnostic Tests Introduction

　　10.22.4 Company 22 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.22.5 Company 22 Recent Development

　13.23 Company 23

　　10.23.1 Company 23 Company Details

　　10.23.2 Company 23 Business Overview and Its Total Revenue

　　10.23.3 Company 23 Precision Cancer Diagnostic Tests Introduction

　　10.23.4 Company 23 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.23.5 Company 23 Recent Development

　13.24 Company 24

　　10.24.1 Company 24 Company Details

　　10.24.2 Company 24 Business Overview and Its Total Revenue

　　10.24.3 Company 24 Precision Cancer Diagnostic Tests Introduction

　　10.24.4 Company 24 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.24.5 Company 24 Recent Development

　13.25 Company 25

　　10.25.1 Company 25 Company Details

　　10.25.2 Company 25 Business Overview and Its Total Revenue

　　10.25.3 Company 25 Precision Cancer Diagnostic Tests Introduction

　　10.25.4 Company 25 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.25.5 Company 25 Recent Development

　13.26 Company 26

　　10.26.1 Company 26 Company Details

　　10.26.2 Company 26 Business Overview and Its Total Revenue

　　10.26.3 Company 26 Precision Cancer Diagnostic Tests Introduction

　　10.26.4 Company 26 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.26.5 Company 26 Recent Development

　13.27 Company 27

　　10.27.1 Company 27 Company Details

　　10.27.2 Company 27 Business Overview and Its Total Revenue

　　10.27.3 Company 27 Precision Cancer Diagnostic Tests Introduction

　　10.27.4 Company 27 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.27.5 Company 27 Recent Development

　13.28 Company 28

　　10.28.1 Company 28 Company Details

　　10.28.2 Company 28 Business Overview and Its Total Revenue

　　10.28.3 Company 28 Precision Cancer Diagnostic Tests Introduction

　　10.28.4 Company 28 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)

　　10.28.5 Company 28 Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

　15.1 Research Methodology

　　15.1.1 Methodology/Research Approach

　　15.1.2 Data Source

　15.2 Disclaimer

　15.3 Author Details

List of Tables

　Table 1. Precision Cancer Diagnostic Tests Key Market Segments

　Table 2. Key Players Covered: Ranking by Precision Cancer Diagnostic Tests Revenue

　Table 3. Ranking of Global Top Precision Cancer Diagnostic Tests Manufacturers by Revenue (US$ Million) in 2019

　Table 4. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

　Table 5. Key Players of Imaging

　Table 6. Key Players of Molecular

　Table 7. Key Players of Histology/Cytology

　Table 8. Key Players of Tumor Marker Immunoassays

　Table 9. Key Players of POC Colon Cancer Tests

　Table 10. Global Precision Cancer Diagnostic Tests Market Size Growth by Application (US$ Million): 2020 VS 2026

　Table 11. Global Precision Cancer Diagnostic Tests Market Size by Regions (US$ Million): 2020 VS 2026

　Table 12. Global Precision Cancer Diagnostic Tests Market Size by Regions (2015-2020) (US$ Million)

　Table 13. Global Precision Cancer Diagnostic Tests Market Share by Regions (2015-2020)

　Table 14. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Regions (2021-2026) (US$ Million)

全球精密癌癥診斷測試市場規模，現狀和展望二零二零年至2026年

　Table 15. Global Precision Cancer Diagnostic Tests Market Share by Regions (2021-2026)

　Table 16. Market Top Trends

　Table 17. Key Drivers: Impact Analysis

　Table 18. Key Challenges

　Table 19. Precision Cancer Diagnostic Tests Market Growth Strategy

　Table 20. Main Points Interviewed from Key Precision Cancer Diagnostic Tests Players

　Table 21. Global Precision Cancer Diagnostic Tests Revenue by Players (2015-2020) (Million US$)

　Table 22. Global Precision Cancer Diagnostic Tests Market Share by Players (2015-2020)

　Table 23. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Diagnostic Tests as of 2019)

　Table 24. Global Precision Cancer Diagnostic Tests by Players Market Concentration Ratio (CR5 and HHI)

　Table 25. Key Players Headquarters and Area Served

　Table 26. Key Players Precision Cancer Diagnostic Tests Product Solution and Service

　Table 27. Date of Enter into Precision Cancer Diagnostic Tests Market

　Table 28. Mergers & Acquisitions, Expansion Plans

　Table 29. Global Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)

　Table 30. Global Precision Cancer Diagnostic Tests Market Size Share by Type (2015-2020)

　Table 31. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2021-2026)

　Table 32. Global Precision Cancer Diagnostic Tests Market Size Share by Application (2015-2020)

　Table 33. Global Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)

　Table 34. Global Precision Cancer Diagnostic Tests Market Size Share by Application (2021-2026)

　Table 35. North America Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)

　Table 36. North America Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)

　Table 37. North America Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)

　Table 38. North America Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)

　Table 39. North America Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)

　Table 40. North America Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)

　Table 41. Europe Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)

　Table 42. Europe Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)

　Table 43. Europe Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)

　Table 44. Europe Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)

　Table 45. Europe Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)

　Table 46. Europe Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)

　Table 47. China Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)

　Table 48. China Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)

　Table 49. China Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)

　Table 50. China Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)

　Table 51. China Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)

　Table 52. China Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)

　Table 53. Japan Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)

　Table 54. Japan Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)

　Table 55. Japan Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)

　Table 56. Japan Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)

　Table 57. Japan Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)

　Table 58. Japan Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)

　Table 59. Southeast Asia Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)

　Table 60. Southeast Asia Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)

　Table 61. Southeast Asia Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)

　Table 62. Southeast Asia Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)

　Table 63. Southeast Asia Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)

　Table 64. Southeast Asia Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)

　Table 65. India Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)

　Table 66. India Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)

　Table 67. India Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)

　Table 68. India Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)

　Table 69. India Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)

　Table 70. India Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)

　Table 71. Central & South America Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)

　Table 72. Central & South America Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)

　Table 73. Central & South America Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)

　Table 74. Central & South America Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)

　Table 75. Central & South America Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)

　Table 76. Central & South America Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)

　Table 77. Company 1 Company Details

　Table 78. Company 1 Business Overview

　Table 79. Company 1 Product

　Table 80. Company 1 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 81. Company 1 Recent Development

　Table 82. Company 2 Company Details

　Table 83. Company 2 Business Overview

　Table 84. Company 2 Product

　Table 85. Company 2 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 86. Company 2 Recent Development

　Table 87. Company 3 Company Details

　Table 88. Company 3 Business Overview

　Table 89. Company 3 Product

　Table 90. Company 3 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 91. Company 3 Recent Development

　Table 92. Company 4 Company Details

　Table 93. Company 4 Business Overview

　Table 94. Company 4 Product

　Table 95. Company 4 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 96. Company 4 Recent Development

　Table 97. Company 5 Company Details

　Table 98. Company 5 Business Overview

　Table 99. Company 5 Product

　Table 100. Company 5 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 101. Company 5 Recent Development

　Table 102. Company 6 Company Details

　Table 103. Company 6 Business Overview

　Table 104. Company 6 Product

　Table 105. Company 6 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 106. Company 6 Recent Development

　Table 107. Company 7 Company Details

　Table 108. Company 7 Business Overview

　Table 109. Company 7 Product

　Table 110. Company 7 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 111. Company 7 Recent Development

　Table 112. Company 8 Business Overview

　Table 113. Company 8 Product

　Table 114. Company 8 Company Details

　Table 115. Company 8 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 116. Company 8 Recent Development

　Table 117. Company 9 Company Details

　Table 118. Company 9 Business Overview

　Table 119. Company 9 Product

　Table 120. Company 9 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 121. Company 9 Recent Development

　Table 122. Company 10 Company Details

　Table 123. Company 10 Business Overview

　Table 124. Company 10 Product

quánqiú jīngmì áizhèng zhěnduàn cèshìshìchǎng guīmó, xiànzhuàng hé zhǎnwàng èr líng èr líng nián zhì 2026 nián

　Table 125. Company 10 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 126. Company 10 Recent Development

　Table 127. Company 11 Company Details

　Table 128. Company 11 Business Overview

　Table 129. Company 11 Product

　Table 130. Company 11 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 131. Company 11 Recent Development

　Table 132. Company 12 Company Details

　Table 133. Company 12 Business Overview

　Table 134. Company 12 Product

　Table 135. Company 12 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 136. Company 12 Recent Development

　Table 137. Company 13 Company Details

　Table 138. Company 13 Business Overview

　Table 139. Company 13 Product

　Table 140. Company 13 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 141. Company 13 Recent Development

　Table 142. Company 14 Company Details

　Table 143. Company 14 Business Overview

　Table 144. Company 14 Product

　Table 145. Company 14 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 146. Company 14 Recent Development

　Table 147. Company 15 Company Details

　Table 148. Company 15 Business Overview

　Table 149. Company 15 Product

　Table 150. Company 15 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 151. Company 15 Recent Development

　Table 152. Company 16 Company Details

　Table 153. Company 16 Business Overview

　Table 154. Company 16 Product

　Table 155. Company 16 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 156. Company 16 Recent Development

　Table 157. Company 17 Company Details

　Table 158. Company 17 Business Overview

　Table 159. Company 17 Product

　Table 160. Company 17 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 161. Company 17 Recent Development

　Table 162. Company 18 Company Details

　Table 163. Company 18 Business Overview

　Table 164. Company 18 Product

　Table 165. Company 18 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 166. Company 18 Recent Development

　Table 167. Company 19 Company Details

　Table 168. Company 19 Business Overview

　Table 169. Company 19 Product

　Table 170. Company 19 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 171. Company 19 Recent Development

　Table 172. Company 20 Company Details

　Table 173. Company 20 Business Overview

　Table 174. Company 20 Product

　Table 175. Company 20 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 176. Company 20 Recent Development

　Table 177. Company 21 Company Details

　Table 178. Company 21 Business Overview

　Table 179. Company 21 Product

　Table 180. Company 21 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 181. Company 21 Recent Development

　Table 182. Company 22 Company Details

　Table 183. Company 22 Business Overview

　Table 184. Company 22 Product

　Table 185. Company 22 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 186. Company 22 Recent Development

　Table 187. Company 23 Company Details

　Table 188. Company 23 Business Overview

　Table 189. Company 23 Product

　Table 190. Company 23 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 191. Company 23 Recent Development

　Table 192. Company 24 Company Details

　Table 193. Company 24 Business Overview

　Table 194. Company 24 Product

　Table 195. Company 24 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 196. Company 24 Recent Development

　Table 197. Company 25 Company Details

　Table 198. Company 25 Business Overview

　Table 199. Company 25 Product

　Table 200. Company 25 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 201. Company 25 Recent Development

　Table 202. Company 26 Company Details

　Table 203. Company 26 Business Overview

　Table 204. Company 26 Product

　Table 205. Company 26 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 206. Company 26 Recent Development

　Table 207. Company 27 Company Details

　Table 208. Company 27 Business Overview

　Table 209. Company 27 Product

　Table 210. Company 27 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 211. Company 27 Recent Development

　Table 212. Company 28 Company Details

　Table 213. Company 28 Business Overview

　Table 214. Company 28 Product

　Table 215. Company 28 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)

　Table 216. Company 28 Recent Development

　Table 217. Research Programs/Design for This Report

　Table 218. Key Data Information from Secondary Sources

　Table 219. Key Data Information from Primary Sources

List of Figures

　Figure 1. Global Precision Cancer Diagnostic Tests Market Share by Type: 2020 VS 2026

　Figure 2. Imaging Features

　Figure 3. Molecular Features

　Figure 4. Histology/Cytology Features

　Figure 5. Tumor Marker Immunoassays Features

　Figure 6. POC Colon Cancer Tests Features

　Figure 7. Global Precision Cancer Diagnostic Tests Market Share by Application: 2020 VS 2026

　Figure 8. Hospital Case Studies

　Figure 9. Clinic Case Studies

グローバル?精密がんの診斷には、市場規模、ステータスおよび予測2020年から2026年をテスト

　Figure 10. Other Case Studies

　Figure 11. Precision Cancer Diagnostic Tests Report Years Considered

　Figure 12. Global Precision Cancer Diagnostic Tests Market Size YoY Growth 2015-2026 (US$ Million)

　Figure 13. Global Precision Cancer Diagnostic Tests Market Share by Regions: 2020 VS 2026

　Figure 14. Global Precision Cancer Diagnostic Tests Market Share by Regions (2021-2026)

　Figure 15. Porter's Five Forces Analysis

　Figure 16. Global Precision Cancer Diagnostic Tests Market Share by Players in 2019

　Figure 17. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Diagnostic Tests as of 2019

　Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Diagnostic Tests Revenue in 2019

　Figure 19. North America Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)

　Figure 20. Europe Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)

　Figure 21. China Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)

　Figure 22. Japan Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)

　Figure 23. Southeast Asia Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)

　Figure 24. India Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)

　Figure 25. Central & South America Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)

　Figure 26. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 27. Company 1 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 28. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 29. Company 2 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 30. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 31. Company 3 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 32. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 33. Company 4 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 34. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 35. Company 5 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 36. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 37. Company 6 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 38. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 39. Company 7 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 40. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 41. Company 8 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 42. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 43. Company 9 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 44. Company 10 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 45. Company 10 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 46. Company 11 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 47. Company 11 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 48. Company 12 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 49. Company 12 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 50. Company 13 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 51. Company 13 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 52. Company 14 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 53. Company 14 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 54. Company 15 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 55. Company 15 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 56. Company 16 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 57. Company 16 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 58. Company 17 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 59. Company 17 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 60. Company 18 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 61. Company 18 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 62. Company 19 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 63. Company 19 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 64. Company 20 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 65. Company 20 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)

　Figure 66. Bottom-up and Top-down Approaches for This Report

　Figure 67. Data Triangulation

　Figure 68. Key Executives Interviewed

　　http://www.qdlaimaiche.com/3/68/Global-Precision-Cancer-Diagnostic-Tests-Market-Size-Status-and-Forecast-2020-2026.html

　　產業調研網

　　省略………